you are viewing a single comment's thread.
Disagree. How many biotech companies do you know sitting on Phase 3 results that are stating in an official PR that they NOT DILUTE OR RAISE CAPITAL.
This is amazing and IF there are some positive events (upgrades and/or insitutional acquirers), I suspect Celsion could really start a big run PRIOR to data release.
Sentiment: Strong Buy